SEC Form D · filed October 14, 2022
NLS Pharmaceutics Ltd
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Chad Hellmann · Zurich, V8ExecRonald Hafner · Zurich, V8DirectorGian-Marco Rinaldi De La Cruz · Zurich, V8DirectorAlexander Zwyer · Zurich, V8Exec · DirectorMyoung-Ok Kwon · Zurich, V8DirectorStig Lokke Pedersen · Zurich, V8DirectorMargaret Sprenger · Ridgefield, CTDirectorPeter Ackerson · Ridgefield, CTExec · DirectorAsuna P. Gilfoyle · NEW YORK, NYExecLisa Sun · New York, NYDirectorDoron Breen · TEL AVIV, L3DirectorGary D. Edmonds · Wayne, PADirectorMartin Lehr · Arlington, MADirectorDhvani D. Shah · Winnipeg, Manitoba, CanadaExecLinda D. Kerrigan · Winnipeg, Manitoba, CanadaDirectorPaul A. Mahon · Winnipeg, Manitoba, CanadaExec · DirectorAmy A. Metzger · Winnipeg, Manitoba, CanadaDirectorFabrice A. Morin · Winnipeg, Manitoba, CanadaDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗